Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

This publication has 38 references indexed in Scilit:

• Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis
  Stroke, 1998
• Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
  Journal of Clinical Investigation, 1998
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
  Journal of Clinical Investigation, 1997
• Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease
  International Journal of Cardiology, 1996
• The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
  Nature Genetics, 1996
• A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic Isolate
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Genetic and environmental effects on coronary heart disease risk factors in Northern Norway. The cardiovascular disease study in Finnmark
  Annals of Human Genetics, 1994
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
  Atherosclerosis, 1993
• Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.
  Stroke, 1990